#1 Clinical Trials Search in Europe

Tadalafil

Tadalafil, a medication primarily known for treating erectile dysfunction, has been the subject of numerous clinical trials exploring its potential benefits in various medical conditions. This article summarizes key findings from clinical studies investigating tadalafil’s efficacy and safety in treating pulmonary arterial hypertension, benign prostatic hyperplasia, Duchenne muscular dystrophy, and other conditions. We’ll explore the drug’s mechanisms, dosing strategies, and potential side effects across different patient populations.

Table of Contents

What is Tadalafil?

Tadalafil is a medication primarily used to treat various conditions related to blood flow and muscle function. It is known by several names, including Cialis, LY450190, and IC351[1]. Tadalafil belongs to a class of drugs called phosphodiesterase type 5 (PDE5) inhibitors, which work by affecting specific enzymes in the body[2].

Conditions Treated by Tadalafil

Tadalafil is used to treat several medical conditions, including:

  • Erectile Dysfunction (ED): This is a condition where men have difficulty getting or maintaining an erection suitable for sexual activity[3].
  • Benign Prostatic Hyperplasia (BPH): This condition involves an enlarged prostate gland, causing urinary symptoms[4].
  • Pulmonary Arterial Hypertension (PAH): This is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart[2].
  • Premature Ejaculation: Some studies are exploring the use of tadalafil for this condition[5].

How Tadalafil Works

Tadalafil works by inhibiting an enzyme called phosphodiesterase type 5 (PDE5). This action helps to relax blood vessels and improve blood flow in specific areas of the body. For erectile dysfunction, it increases blood flow to the penis. In pulmonary arterial hypertension, it helps relax blood vessels in the lungs[2].

Dosage and Administration

The dosage and administration of tadalafil can vary depending on the condition being treated:

  • For erectile dysfunction, doses typically range from 2.5 mg to 20 mg, taken either daily or as needed before sexual activity[3].
  • For benign prostatic hyperplasia, a common dose is 5 mg taken once daily[4].
  • For pulmonary arterial hypertension, doses may range from 20 mg to 40 mg taken once daily[6].

It’s important to note that tadalafil should be taken as prescribed by your doctor, as dosages can vary based on individual factors and the specific condition being treated.

Effectiveness of Tadalafil

Clinical trials have shown tadalafil to be effective in treating various conditions:

  • For erectile dysfunction, studies have shown significant improvements in the ability to achieve and maintain erections[1].
  • In treating benign prostatic hyperplasia, tadalafil has been shown to improve urinary symptoms[4].
  • For pulmonary arterial hypertension, tadalafil has demonstrated improvements in exercise capacity and quality of life[6].

Potential Side Effects

Like all medications, tadalafil can cause side effects. Common side effects may include:

  • Headache
  • Back pain
  • Muscle aches
  • Flushing
  • Nasal congestion
  • Indigestion

It’s important to discuss any side effects with your healthcare provider. In rare cases, more serious side effects can occur, such as prolonged erections or sudden vision or hearing loss[7].

Ongoing Research

Researchers continue to explore new potential uses for tadalafil. Some areas of ongoing research include:

  • Use in treating Duchenne muscular dystrophy, a genetic disorder characterized by progressive muscle degeneration[8].
  • Potential benefits for diabetic patients with gastroparesis, a condition that affects stomach emptying[9].

These studies are still in progress, and more research is needed to determine the effectiveness and safety of tadalafil for these conditions.

Condition Dosage Range Key Outcomes Measured Trial Duration
Pulmonary Arterial Hypertension 2.5 mg – 40 mg daily 6-minute walk distance, WHO functional class, time to clinical worsening 16 weeks to over 52 weeks
Benign Prostatic Hyperplasia 2.5 mg – 20 mg daily International Prostate Symptom Score (IPSS), peak urinary flow 12 weeks
Erectile Dysfunction 2.5 mg – 20 mg, as needed or daily International Index of Erectile Function (IIEF), Sexual Encounter Profile (SEP) 12 weeks
Duchenne Muscular Dystrophy 0.6 mg/kg single dose Vascular responsiveness, exercise capacity Single dose study
Diabetic Gastroparesis 5 mg – 20 mg daily Total Symptom Severity Score, gastric emptying time 8 weeks

FAQ

  • What conditions is tadalafil being studied for in clinical trials? Tadalafil is being studied for various conditions including pulmonary arterial hypertension, benign prostatic hyperplasia, erectile dysfunction, Duchenne muscular dystrophy, and diabetic gastroparesis.
  • How is tadalafil administered in these clinical trials? Tadalafil is typically administered orally as tablets, with dosages ranging from 2.5 mg to 40 mg. The frequency of administration varies depending on the condition being studied, from daily dosing to 'as-needed' use.
  • What are some of the primary outcomes measured in tadalafil clinical trials? Primary outcomes often include changes in disease-specific symptoms, exercise capacity (such as the 6-minute walk distance), quality of life measures, and safety assessments including adverse events.
  • Are there any notable side effects of tadalafil observed in these trials? While specific side effects are not detailed in the provided trial summaries, tadalafil is generally well-tolerated. Common side effects may include headache, back pain, and muscle aches. Safety is a key component of all the clinical trials.
  • How long do these clinical trials typically last? The duration of the clinical trials varies widely, ranging from 12 weeks for some erectile dysfunction studies to over 52 weeks for long-term safety and efficacy studies in pulmonary arterial hypertension.

Ongoing Clinical Trials on Tadalafil

  • A Study Testing if Daily Tadalafil Improves Movement Symptoms in Patients with Early-Stage Parkinson’s Disease Who Have Not Yet Started Treatment

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study comparing tadalafil with ambrisentan versus tadalafil alone in newly diagnosed patients with pulmonary arterial hypertension who have cardiovascular conditions

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Evaluating Citrulline, Folic Acid, Vericiguat, and Tadalafil Combination for Patients with Treatment-Resistant High Blood Pressure

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

  • Long-term Safety Study of Tadalafil and Macitentan for Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Hungary Poland

  • Study on Improving Sexual Function in Men and Women After Rectal Cancer Treatment Using Tadalafil

    Not yet recruiting

    1 1 1
    Investigated drugs:
    Sweden

Glossary

  • Pulmonary Arterial Hypertension (PAH): A condition characterized by high blood pressure in the arteries of the lungs, which can lead to heart failure.
  • Benign Prostatic Hyperplasia (BPH): A non-cancerous enlargement of the prostate gland that can cause urinary symptoms in men.
  • Erectile Dysfunction (ED): The inability to get or maintain an erection firm enough for sexual intercourse.
  • Duchenne Muscular Dystrophy (DMD): A genetic disorder characterized by progressive muscle degeneration and weakness.
  • Gastroparesis: A digestive disorder that slows or stops the movement of food from the stomach to the small intestine.
  • 6-Minute Walk Distance (6MWD): A test that measures the distance an individual can walk in 6 minutes, often used to assess exercise capacity in cardiopulmonary conditions.
  • International Prostate Symptom Score (IPSS): A questionnaire used to screen for, diagnose, and track symptoms of benign prostatic hyperplasia.
  • International Index of Erectile Function (IIEF): A questionnaire used to assess erectile function and response to treatment in clinical trials.
  • Phosphodiesterase Type 5 (PDE5) Inhibitor: A class of drugs that includes tadalafil, which work by increasing blood flow to certain tissues in the body.
  • Blood Oxygen Level-Dependent (BOLD) MRI: An MRI technique used to measure blood flow and oxygenation in tissues, often used in research settings.

References

  1. https://clinicaltrials.gov/study/NCT00547573
  2. https://clinicaltrials.gov/study/NCT00125918
  3. https://clinicaltrials.gov/study/NCT00547495
  4. https://clinicaltrials.gov/study/NCT00384930
  5. https://clinicaltrials.gov/study/NCT05052879
  6. https://clinicaltrials.gov/study/NCT00549302
  7. https://clinicaltrials.gov/study/NCT00547508
  8. https://clinicaltrials.gov/study/NCT05195775
  9. https://clinicaltrials.gov/study/NCT00050609